50 results
424B5
ANNX
Annexon Inc
5 Apr 24
Prospectus supplement for primary offering
4:07pm
of providing enhanced efficacy and offering convenient dosing administration for long-term treatment of chronic conditions.
We hold worldwide development
8-K
EX-99.1
ncm7twnwl2
8 Jan 24
Regulation FD Disclosure
4:09pm
8-K
EX-1.1
ti3s2ala2 le6mf93do1
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
424B5
5o8mcxr6nuw90we
21 Dec 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.2
hupe0hwxv cj9
20 Dec 23
Regulation FD Disclosure
5:17pm
8-K
EX-10.1
7g0dk5563
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm